Articles tagged with Nephropathies
A study found that individuals with high urinary protein levels are at increased risk of developing kidney disease. Screening for albuminuria in the general population or high-risk groups could help prevent kidney function loss and related health issues.
Researchers discovered that many processed and fast foods contain phosphorus additives, which can be just as dangerous for patients with advanced kidney disease as naturally high-phosphorus foods. Studies found that avoiding these additives significantly lowers phosphorus levels among patients.
A recent study published in PLoS ONE found that women who drink two or more cans of soda per day are nearly twice as likely to show early signs of kidney disease. The study also did not find an elevated risk for men or diet soda consumption.
Measuring glomerular filtration rates from routine blood work may not be a cost-effective way to identify people with chronic kidney disease (CKD). The test can lead to 11,348 more false positive CKD cases than serum creatinine reporting.
A phase 3 clinical trial has shown that ferumoxytol, a novel intravenous form of iron, is effective in treating iron deficiency in CKD patients on dialysis. The study found significant improvements in hemoglobin levels compared to oral iron supplementation.
A new formula estimates glomerular filtration rate (GFR) using demographic variables and biochemical markers, providing a valuable tool for pediatricians to monitor kidney function. The equation was found to be comparable with more complicated tests and superior to other recently published equations.
Researchers created a simple model to predict patients at high risk for chronic kidney disease, using an eight-point risk factor checklist. The model accurately stratifies middle-aged and older patients and has been validated across different cohorts.
Studies suggest taking phosphorus binders reduces death risk in new dialysis patients and those with less-severe CKD. The treatment could benefit a larger population of patients with pre-dialysis CKD.
A study published in JASN found that even mild increases in serum phosphorus levels are associated with cardiovascular events in people with moderate chronic kidney disease. Vascular calcification, detected by CT scans, was more common in patients with higher phosphorus levels, increasing the risk of coronary artery calcification.
Researchers at the University of Warwick have discovered that high doses of thiamine can dramatically decrease albumin excretion and reverse early-stage diabetic kidney disease. The study found that 300mg of thiamine taken orally daily for three months reduced albumin excretion by 41% in type 2 diabetes patients.
A study by the American Society of Nephrology found that patients with poor health literacy are less likely to receive kidney transplants. Roughly one-third of dialysis patients had inadequate health literacy, which hindered their ability to navigate healthcare systems and follow transplant instructions.
A study found that acute kidney injury increases the risk of end-stage renal disease among elderly patients, highlighting the importance of close monitoring and timely interventions.
The Canadian Society of Nephrology has released new guidelines to slow progression, prevent complications, and reduce mortality in chronic kidney disease patients. The guidelines encourage shared care among general practitioners and specialists.
A clinical trial found that cognitive-behavioral therapy significantly improves depressive symptoms and quality-of-life scores in patients with kidney disease on dialysis. After three months of weekly sessions, patients showed a substantial reduction in depression and improved cognitive function.
The recently passed Medicare Improvement for Patients and Providers Act of 2008 will significantly impact nephrology practice and patient care. Key provisions include funding for CKD education sessions, bundled payment systems, and quality measures to improve efficiency and outcomes.
Individuals with kidney stones are at a 60% greater risk of developing chronic kidney disease (CKD), according to a new study. Researchers recommend careful monitoring of stone formers and appropriate treatment when needed.
A newly developed equation estimates glomerular filtration rate (GFR) more accurately than the widely used Modification of Diet in Renal Disease (MDRD) Study equation, especially at higher GFR levels. The CKD-EPI equation was validated using data from over 8,000 patients and shows lower bias compared to the MDRD equation.
A study compared the survival of dialysis patients undergoing heart bypass surgery or stent placement, finding that stents offer best one-year survival but bypass surgery is superior for long-term results. The study's findings suggest that treatment choices depend on individual patient goals and risk tolerance.
Research presented at the American Society of Nephrology's Annual Meeting found African Americans with CKD caused by high blood pressure have a higher risk of progression to ESRD. The study followed 691 patients for 11 years and found they were at higher risk of progressing to ESRD than experiencing cardiovascular events.
Researchers found improved cognitive function in transplant patients, particularly in verbal learning and memory. In contrast, dialysis patients showed declining test scores over time. The study suggests that kidney transplantation may have a beneficial effect on patients' mental function.
A study of 107,693 Canadians found Aboriginal people with severe kidney disease were 43% less likely to visit a nephrologist and almost twice as likely to be hospitalized for preventable conditions. Understanding the barriers to healthcare is crucial to addressing these inequities.
The Halpin Foundation has awarded a research grant to Dr. Elena Torban, focusing on podocytes and their role in preventing proteinuria in nephrotic syndrome. This funding will support her investigation into the cell and molecular basis of this kidney disease.
The Rutgers University Cell and DNA Repository has received two major NIH awards to support investigations into the genetics of mental disorders, metabolic diseases, and digestive health. The funds will enable researchers to study the genetic causes of complex diseases such as autism, bipolar disorder, and diabetes.
TheVisualMD.com offers interactive 3D visualizations of the cardiovascular system and various disease states. The platform provides a rich visual experience for professionals and patients to increase understanding and compliance.
A study found that hospitalized patients with chronic kidney disease (CKD) are at higher risk of experiencing adverse consequences of medical care. CKD patients were more likely to experience complications such as infections, respiratory failure, and post-operative hip fractures.
A study found that high levels of alkaline phosphatase, a marker of bone disease, are associated with an increased risk of death in dialysis patients. Patients with elevated alkaline phosphatase levels were 25% more likely to die over a three-year period.
The American Society of Nephrology discusses the merits of using eGFR for early detection and treatment of CKD, highlighting concerns about misclassification and universal screening. Experts emphasize the need for education and proper use of eGFR to ensure accurate diagnosis and management.
A study found that patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD) were less likely to use recommended medications after a heart attack, but 1-year adherence rates were similar for both groups. Rates of medication use varied significantly among different types of drugs.
Researchers found that consistently controlling parathyroid hormone, calcium, and phosphorous levels can prolong the lives of hemodialysis patients. Meeting multiple targets simultaneously was associated with improved survival rates, with a 51% higher risk of death for those who failed to meet any targets.
A cohort of half a million patients in Taiwan found that chronic kidney disease has a high prevalence and associated all-cause mortality, especially in low socioeconomic status groups. CKD is treatable and preventable at earlier stages, but awareness and treatment are often lacking globally.
A study by Drs. Seungho Ryu and Yoosoo Chang found that healthy individuals who gain weight, even up to a normal BMI, are at increased risk for developing chronic kidney disease. The U-shaped association between weight change and CKD development suggests that both significant weight loss and gain pose risks.
A study found that CKD patients have mild reductions in thyroid function, which may be a risk factor for cardiovascular disease and progressive kidney disease. The prevalence of subclinical hypothyroidism increased with declining kidney function.
A study found that non-alcoholic fatty liver disease (NAFLD) is linked to an increased risk of chronic kidney disease (CKD) in type 2 diabetes patients. NAFLD was associated with a 69% higher risk of CKD compared to those without the condition.
A study found that black patients with chronic kidney disease (CKD) have a higher risk of dying in the early stages of the disease compared to white patients. The disparities are attributed to sociological factors, including poverty and access-to-care, rather than biological differences.
Patients with systolic dysfunction are nearly twice as likely to die than those without the condition, according to a study analyzing 2,718 kidney transplant candidates. This increased mortality risk is similar to that seen in patients with cardiac ischemia.
A study found that activated vitamin D may reduce the risk of death by approximately one-fourth in patients with CKD, with a 20% reduction in the risk of either death or dialysis
Research by Johns Hopkins Medicine found that African-American patients with chronic kidney disease continue to lose kidney function despite strict blood pressure control. The study suggests that treating CKD in this population may require a more comprehensive approach, considering other factors beyond just blood pressure.
Researchers at UC San Diego School of Medicine found that low levels of adiponectin, a hormone produced by fat cells, are linked to elevated albumin protein in the urine and increased inflammation in the kidney. The study suggests that supplementing with adiponectin or other therapies may help protect kidney function in obese patients.
Researchers found that higher creatinine levels in black patients with kidney disease cannot be explained by differences in muscle mass. The study suggests new theories are needed to account for the racial difference, which could help explain why blacks are more affected by progressive chronic kidney disease.
A study published in the Journal of the American Society Nephrology found that raloxifene increases bone mineral density and reduces vertebral fractures in postmenopausal women with mild to moderate chronic kidney disease. The medication is safe and effective for this patient population, reversing bone loss and fracture risk.
A study found that elevated uric acid levels can precede significant changes in urine albumin levels, suggesting a potential early sign of diabetic kidney disease. Higher uric acid levels are associated with lower kidney function in patients with type 1 diabetes.
Two studies suggest that universal access to healthcare can reduce racial and ethnic barriers to treatment for kidney disease. Minority patients and those on Medicare or with less education had longer dialysis times before being wait-listed, highlighting the need for improved insurance coverage.
Researchers found that a protein called hypoxia-inducible-factor (HIF-1) promotes the synthesis of fibrous connective tissue in kidneys, leading to reduced oxygenation and progression of chronic kidney disease. The study used mice with silenced HIF-1a to demonstrate the link between low oxygen conditions and CKD.
Researchers predict a sharp increase in the US ESRD population by 2020, with over 785,000 patients expected to be affected. The study attributes this growth to the aging of Baby Boomers and rising diabetes rates.
Renal experts will discuss link between chronic kidney disease (CKD) and CVD, consequences of acute kidney injury, racial disparities in kidney disease outcomes, and treatment of anemia in kidney patients. The ASN's Public Policy News Briefing aims to improve health outcomes by highlighting significant research impacting public health.
Research suggests that frequent nocturnal hemodialysis can reduce the need for blood pressure medications and improve quality of life measures. However, it did not show benefits in anemia management. The study found reduced left ventricular hypertrophy and improved mineral metabolism.
A randomized controlled trial found that treating patients with chronic kidney disease with high doses of folic acid and B vitamins did not lower the rate of death or cardiovascular events. The study suggests that the underlying burden of disease may be too great to produce a measurable benefit from lowering homocysteine levels.
Recent progress in preventing and treating end-stage renal disease (ESRD) in the US is cause for cautious optimism, with improvements in survival expectations and increased use of fistulas for hemodialysis. However, skyrocketing costs are a major concern, with Medicare costs reaching $20.1 billion in 2004.
Women with diabetes lose protective effect of estrogen on kidneys, which normally reduces risk of chronic kidney disease. Research suggests that hormone ratio rather than absolute levels determines impact on diabetic kidney disease.
A study found that obesity is associated with higher levels of parathyroid hormone in patients with moderate to severe chronic kidney disease. Weight loss may help lower PTH levels, while other treatments could lead to weight loss. The association was strongest in patients with signs of malnutrition and inflammation.
Researchers have discovered that combining two blood pressure-lowering drugs with enzyme replacement therapy can slow the progression of kidney disease in patients with severe Fabry disease. The study found significant reductions in proteinuria and minimal decline in kidney function after an average of two and a half years' treatment.
A study reveals that hemoglobin levels vary among dialysis patients due to negative feedback control systems and individual sensitivity to ESA treatment. The analysis suggests optimizing treatment systems on a rational basis to reduce variation in hemoglobin values and stabilize dose regimens.
Researchers found that early treatment with ACE inhibitors can preserve kidney function and reduce the risk of irreversible damage in young patients with early-stage IgA nephropathy. The study suggests that starting treatment early may limit the need for renal replacement therapy.
Ms Bhavini Patel, Director of Pharmacy at Royal Darwin Hospital, has received a two-year Fellowship to address the evidence-practice gap in treating chronic kidney disease in Indigenous Australians. She aims to increase use of arteriovenous fistula for haemodialysis, reducing hospitalizations and complications.
The University of Virginia Health System has received a $583,000 NIH training grant to train four new researchers in kidney disease research annually. This multidisciplinary program aims to address the growing problem of kidney disease by equipping researchers with skills to translate lab research to clinical practice.
Chronic kidney disease affects a significant portion of the UK population, particularly elderly individuals taking multiple medications. Healthcare professionals require specific guidance on using drugs that can cause or be altered by kidney disease, as 'use with caution' advice is often insufficient.
Long-term Fosrenol treatment improves bone formation and reduces phosphorus levels in CKD stage 5 patients, according to a two-year study. The reformulated tablets also demonstrate efficacy as monotherapy for controlling serum phosphorus levels.
A Rutgers College of Nursing professor is testing a 12-week home-based exercise intervention program to improve physical functioning in older adults with CKD. The study aims to evaluate the feasibility of this program for a larger clinical trial and address the lack of targeted physical activity interventions for this population.
A new study published in Kidney International found that Fosrenol, a phosphate binder used to treat hyperphosphatemia in CKD Stage 5 patients, did not negatively impact cognitive function deterioration. The two-year trial compared Fosrenol with standard therapy and showed similar declines in cognitive function for both groups.
Patients with end-stage renal disease have a significantly shorter life expectancy after ICD implantation, highlighting the need for continued research on prevention and treatment strategies. The study calls into question the survival benefit of ICDs in patients with kidney disease who meet current implant indications.